Back to Rankings

AXTI

AXTB
Nasdaq / Semiconductors & Semiconductor Equipment
Last Price
At close
2026-06-03
View Chart

AI scenario view

RankAlpha Sentiment Codex
B+
Bull case
0%
Probability
Target price
$115.00
+7.8% vs current
Most likely
B
Base case
0%
Probability
Target price
$74.00
-30.6% vs current
B-
Bear case
0%
Probability
Target price
$48.00
-55.0% vs current

AI sentiment snapshot

Latest data as of 2026-05-03
Recent news sentiment (30D)
+16.7
Positive
Company
+17.2
Positive
Macro
+20.7
Positive
Pulse
-62.0
Negative
Sentiment proxy
+15.7
Score

AI commentary

Headline tone turned positive after the April 30, 2026 earnings release because Q1 results improved and management linked the fresh $632.5M raise to AI-related InP capacity expansion. The immediate tape also stayed elevated, with the packet's anchor at $96 on 2026-05-01 versus the April 21 offering price of $64.25. Still, analyst revision visibility remains thin at T+3, so the setup reads more like a high-buzz monitoring story than a fully validated fundamental rerating.

RankAlpha Sentiment Codex - 2026-05-03
Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact
standard
Confidence
-

AI events

2026-05-30catalystQ1 operating reset plus funded InP expansion [#8-K-2026-04-30]High impact

AXT confirmed Q1 2026 revenue of $26.9M versus $19.4M a year earlier, GAAP gross margin of 29.6% versus negative margin a year ago, and said the just-completed $632.5M capital raise will support Tongmei indium phosphide capacity expansion and 6-inch InP R&D tied to AI optical demand [#8-K-2026-04-30].

2026-08-01eventExport-permit cadence remains the key swing factor [#10-K-2026-03-17]High impact

AXT's 2025 10-K says China added indium phosphide substrates to its export control list, that InP export permits are the company's most significant challenge, and that timing for broader approvals including U.S. shipments remains uncertain even after some permits resumed to Europe and Japan [#10-K-2026-03-17].

2027-05-03catalystTongmei STAR Market path and capacity monetization are still unproven [#10-K-2026-03-17]High impact

AXT continues to frame Tongmei's STAR Market listing as a possible value-unlock path, but the 10-K says it still needs CSRC and other approvals and notes investor redemption rights if the IPO fails; the new equity raise gives funding, yet execution and approval timing remain open [#10-K-2026-03-17].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-05-03 • Updated nightlySource: Internal modelMethodology